Cardiomyopathy encompasses a diverse group of myocardial disorders—dilated, hypertrophic, restrictive, arrhythmogenic, and noncompaction—that can lead to heart failure, arrhythmias, and sudden death. This session provides a structured approach to classifying cardiomyopathies based on phenotype, etiology, and genetic background. Participants will learn how to integrate history, physical examination, ECG, imaging, and family information to differentiate primary genetic forms from secondary causes such as toxins, ischemia, autoimmune disease, or infiltrative processes. The goal is to move beyond a generic “weak heart” label toward precise diagnoses that guide targeted management.

Many clinicians and trainees search for a cardiology conference to keep pace with evolving classifications and therapies. This session reviews key features of dilated, hypertrophic, restrictive, and arrhythmogenic right ventricular cardiomyopathy, as well as emerging entities. Attendees will examine how echocardiography, cardiac MRI, and sometimes biopsy contribute to diagnosis, and how to recognize red flags that suggest inherited disease requiring family screening. Case-based discussions highlight challenging scenarios such as overlapping phenotypes, borderline wall thickness, or coexisting coronary disease.

A major focus is implementing comprehensive cardiomyopathy management strategies. Participants will explore guideline-directed heart failure therapy, risk stratification for ICD implantation, and indications for septal reduction therapy, transplant, or mechanical circulatory support. The session addresses exercise recommendations, pregnancy counselling, and sports eligibility, particularly in hypertrophic and arrhythmogenic cardiomyopathies. Genetic testing and cascade screening are discussed in collaboration with cardio genomics and inherited arrhythmia services, ensuring that at-risk relatives receive appropriate evaluation and follow-up.

The session also considers psychosocial aspects—coping with chronic disease, fear of sudden death, and navigating lifestyle modifications. Attendees will gain practical tools for patient education, shared decision-making, and coordination with multidisciplinary teams including heart failure, EP, genetics, and transplant specialists. By the end, participants will have a clear framework for diagnosing, treating, and following patients with cardiomyopathy across the disease spectrum.